In-stent restenosis of drug-eluting stents

被引：10
|
作者：
Minha, Sa'ar [1 ,2 ]
Pichard, Augusto D. [1 ,2 ]
Waksman, Ron [1 ,2 ]
机构：
[1] MedStar Washington Hosp Ctr, Intervent Cardiol, Washington, DC USA
[2] MedStar Washington Hosp Ctr, Washington, DC 20010 USA
来源：
FUTURE CARDIOLOGY | 2013年 / 9卷 / 05期
关键词：
bare metal stent; drug-eluting stent; in-stent restenosis;
D O I：
10.2217/FCA.13.45
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic dilemma. Recent insights regarding the pathophysiological processes and therapeutic alternatives have added to the accumulated knowledge regarding the appropriate approach to this phenomenon. This review aims to detail the mechanism and clinical presentation of, and therapeutic strategies for, the treatment of DES in in-stent restenosis.
引用
收藏
页码：721 / 731
页数：11
相关论文
共 50 条
  • [1] Drug-eluting stents: In-stent restenosis
    Fernandez Murga, Arturo J.
    [J]. REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2010, 39 (04): : 319 - 323
  • [2] Drug-Eluting Stents in the Treatment of In-Stent Restenosis
    Cherian, Sonia
    Sebastian, Cherian
    Puri, Aniket
    Liang, Michael
    Ten, Yuli
    Devlin, Gerard
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 71B - 71B
  • [3] Drug-eluting stents and patterns of in-stent restenosis.
    Mehran, R
    Kesanakurthy, S
    Dangas, GD
    Iyer, S
    Spatareanu, C
    Elliott, N
    Bajraktari, F
    Lander, J
    Nikitina, A
    Moussa, I
    Kreps, E
    Collins, M
    Moses, JW
    Stone, GW
    Leon, MB
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 211E - 211E
  • [4] Drug-eluting stents for diabetic patients with in-stent restenosis
    Hausleiter, J.
    Kastrati, A.
    Schuehlen, H.
    Mehilli, J.
    Dibra, A.
    Pache, J.
    Dirschinger, J.
    Schoemig, A.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 709 - 709
  • [5] In-stent restenosis treatment with sirolimus drug-eluting stents
    Teles, R
    Gonçalves, PA
    Almeida, MS
    Martins, V
    Batista, C
    Seabra-Gomes, R
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 88L - 88L
  • [6] Drug-eluting stents for the treatment of in-stent restenosis A clinical review
    Yan, Bryan P. Y.
    Ajani, Andrew E.
    Waksman, Ron
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2005, 6 (01) : 38 - 43
  • [7] Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
    Nojima, Yuhei
    Yasuoka, Yoshinori
    Kume, Kiyoshi
    Adachi, Hidenori
    Hattori, Susumu
    Matsutera, Ryo
    Kohama, Yasuaki
    Sasaki, Tatsuya
    [J]. CORONARY ARTERY DISEASE, 2014, 25 (08) : 638 - 644
  • [8] In-Stent Restenosis in the Drug-Eluting Stent Era
    Dangas, George D.
    Claessen, Bimmer E.
    Caixeta, Adriano
    Sanidas, Elias A.
    Mintz, Gary S.
    Mehran, Roxana
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (23) : 1897 - 1907
  • [9] Drug-eluting stants and in-stent restenosis
    Alfonso, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (15): : 1855 - 1855
  • [10] Establishing the Safety of Intracoronary Brachytherapy for In-Stent Restenosis of Drug-Eluting Stents
    Ohri, N.
    Sharma, S.
    Kini, A.
    Baber, U.
    Aquino, M.
    Roy, S.
    Buckstein, M.
    Bakst, R. L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E464 - E465
12345